The dedication of Teva Neuroscience to helping people take a total approach to managing multiple sclerosis has guided business decisions since the founding of the company. The company will continue to introduce new programs and services and expand existing programs to help patients, families, caregivers, and health professionals deal with a difficult disease.

For information on Multiple Sclerosis, please click here.

For information on COPAXONE^®, please click here.

In addition, we are confident that this total approach could be applied to other neurological disorders that are, like MS, complicated, devastating diseases. We will maintain our
commitment to MS, but we are exploring opportunities to expand that commitment to providing therapy and hope to people living with other neurological illnesses.

For information on Parkinson's Disease, please click here.

For information on AZILECT^®, please click here

If you would like more information about products currently in development by Teva Pharmaceuticals, please click here.